Pfizer Inc.
Pyrrolo[2,3-d]pyrimidine derivatives

Last updated:

Abstract:

Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, pharmaceutical compositions containing them, and therapeutic uses thereof.

Status:
Grant
Type:

Utility

Filling date:

10 Aug 2015

Issue date:

6 Apr 2021